Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

March 01, 1999; 52 (4) Article

Primary and transitional progressive MS

A clinical and MRI cross-sectional study

V.L. Stevenson, D.H. Miller, M. Rovaris, F. Barkhof, B. Brochet, V. Dousset, V. Dousset, M. Filippi, X. Montalban, C.H. Polman, A. Rovira, J. de Sa, A.J. Thompson
First published March 1, 1999, DOI: https://doi.org/10.1212/WNL.52.4.839
V.L. Stevenson
From the NMR Research Unit (Drs. StevensonMiller, and Thompson), Institute of Neurology, Queen Square, London, UK; Neuroimaging Research Unit (Drs. Rovaris and Filippi), Department of Neuroscience, Scientific Institute Ospidale San Raffaele, University of Milan, Italy; University Hospital Free University (Drs. Barkhof and Polman), Amsterdam, the Netherlands; Departments of Neurology and Neuroradiology (Drs. Brochet, Dousset, and Dousset), Hopital Pellegrin, Bordeaux, France; Unitat de Neuroimmunologia Clinica (Drs. Montalban and Rovira), Hospital Vall d’Hebron, Barcelona, Spain; and Servico de Neurologia (Dr. de Sa), Hospital de Santa Maria, Lisbon, Portugal.
MRCP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D.H. Miller
From the NMR Research Unit (Drs. StevensonMiller, and Thompson), Institute of Neurology, Queen Square, London, UK; Neuroimaging Research Unit (Drs. Rovaris and Filippi), Department of Neuroscience, Scientific Institute Ospidale San Raffaele, University of Milan, Italy; University Hospital Free University (Drs. Barkhof and Polman), Amsterdam, the Netherlands; Departments of Neurology and Neuroradiology (Drs. Brochet, Dousset, and Dousset), Hopital Pellegrin, Bordeaux, France; Unitat de Neuroimmunologia Clinica (Drs. Montalban and Rovira), Hospital Vall d’Hebron, Barcelona, Spain; and Servico de Neurologia (Dr. de Sa), Hospital de Santa Maria, Lisbon, Portugal.
FRCP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Rovaris
From the NMR Research Unit (Drs. StevensonMiller, and Thompson), Institute of Neurology, Queen Square, London, UK; Neuroimaging Research Unit (Drs. Rovaris and Filippi), Department of Neuroscience, Scientific Institute Ospidale San Raffaele, University of Milan, Italy; University Hospital Free University (Drs. Barkhof and Polman), Amsterdam, the Netherlands; Departments of Neurology and Neuroradiology (Drs. Brochet, Dousset, and Dousset), Hopital Pellegrin, Bordeaux, France; Unitat de Neuroimmunologia Clinica (Drs. Montalban and Rovira), Hospital Vall d’Hebron, Barcelona, Spain; and Servico de Neurologia (Dr. de Sa), Hospital de Santa Maria, Lisbon, Portugal.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. Barkhof
From the NMR Research Unit (Drs. StevensonMiller, and Thompson), Institute of Neurology, Queen Square, London, UK; Neuroimaging Research Unit (Drs. Rovaris and Filippi), Department of Neuroscience, Scientific Institute Ospidale San Raffaele, University of Milan, Italy; University Hospital Free University (Drs. Barkhof and Polman), Amsterdam, the Netherlands; Departments of Neurology and Neuroradiology (Drs. Brochet, Dousset, and Dousset), Hopital Pellegrin, Bordeaux, France; Unitat de Neuroimmunologia Clinica (Drs. Montalban and Rovira), Hospital Vall d’Hebron, Barcelona, Spain; and Servico de Neurologia (Dr. de Sa), Hospital de Santa Maria, Lisbon, Portugal.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B. Brochet
From the NMR Research Unit (Drs. StevensonMiller, and Thompson), Institute of Neurology, Queen Square, London, UK; Neuroimaging Research Unit (Drs. Rovaris and Filippi), Department of Neuroscience, Scientific Institute Ospidale San Raffaele, University of Milan, Italy; University Hospital Free University (Drs. Barkhof and Polman), Amsterdam, the Netherlands; Departments of Neurology and Neuroradiology (Drs. Brochet, Dousset, and Dousset), Hopital Pellegrin, Bordeaux, France; Unitat de Neuroimmunologia Clinica (Drs. Montalban and Rovira), Hospital Vall d’Hebron, Barcelona, Spain; and Servico de Neurologia (Dr. de Sa), Hospital de Santa Maria, Lisbon, Portugal.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
V. Dousset
From the NMR Research Unit (Drs. StevensonMiller, and Thompson), Institute of Neurology, Queen Square, London, UK; Neuroimaging Research Unit (Drs. Rovaris and Filippi), Department of Neuroscience, Scientific Institute Ospidale San Raffaele, University of Milan, Italy; University Hospital Free University (Drs. Barkhof and Polman), Amsterdam, the Netherlands; Departments of Neurology and Neuroradiology (Drs. Brochet, Dousset, and Dousset), Hopital Pellegrin, Bordeaux, France; Unitat de Neuroimmunologia Clinica (Drs. Montalban and Rovira), Hospital Vall d’Hebron, Barcelona, Spain; and Servico de Neurologia (Dr. de Sa), Hospital de Santa Maria, Lisbon, Portugal.
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
V. Dousset
From the NMR Research Unit (Drs. StevensonMiller, and Thompson), Institute of Neurology, Queen Square, London, UK; Neuroimaging Research Unit (Drs. Rovaris and Filippi), Department of Neuroscience, Scientific Institute Ospidale San Raffaele, University of Milan, Italy; University Hospital Free University (Drs. Barkhof and Polman), Amsterdam, the Netherlands; Departments of Neurology and Neuroradiology (Drs. Brochet, Dousset, and Dousset), Hopital Pellegrin, Bordeaux, France; Unitat de Neuroimmunologia Clinica (Drs. Montalban and Rovira), Hospital Vall d’Hebron, Barcelona, Spain; and Servico de Neurologia (Dr. de Sa), Hospital de Santa Maria, Lisbon, Portugal.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Filippi
From the NMR Research Unit (Drs. StevensonMiller, and Thompson), Institute of Neurology, Queen Square, London, UK; Neuroimaging Research Unit (Drs. Rovaris and Filippi), Department of Neuroscience, Scientific Institute Ospidale San Raffaele, University of Milan, Italy; University Hospital Free University (Drs. Barkhof and Polman), Amsterdam, the Netherlands; Departments of Neurology and Neuroradiology (Drs. Brochet, Dousset, and Dousset), Hopital Pellegrin, Bordeaux, France; Unitat de Neuroimmunologia Clinica (Drs. Montalban and Rovira), Hospital Vall d’Hebron, Barcelona, Spain; and Servico de Neurologia (Dr. de Sa), Hospital de Santa Maria, Lisbon, Portugal.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
X. Montalban
From the NMR Research Unit (Drs. StevensonMiller, and Thompson), Institute of Neurology, Queen Square, London, UK; Neuroimaging Research Unit (Drs. Rovaris and Filippi), Department of Neuroscience, Scientific Institute Ospidale San Raffaele, University of Milan, Italy; University Hospital Free University (Drs. Barkhof and Polman), Amsterdam, the Netherlands; Departments of Neurology and Neuroradiology (Drs. Brochet, Dousset, and Dousset), Hopital Pellegrin, Bordeaux, France; Unitat de Neuroimmunologia Clinica (Drs. Montalban and Rovira), Hospital Vall d’Hebron, Barcelona, Spain; and Servico de Neurologia (Dr. de Sa), Hospital de Santa Maria, Lisbon, Portugal.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C.H. Polman
From the NMR Research Unit (Drs. StevensonMiller, and Thompson), Institute of Neurology, Queen Square, London, UK; Neuroimaging Research Unit (Drs. Rovaris and Filippi), Department of Neuroscience, Scientific Institute Ospidale San Raffaele, University of Milan, Italy; University Hospital Free University (Drs. Barkhof and Polman), Amsterdam, the Netherlands; Departments of Neurology and Neuroradiology (Drs. Brochet, Dousset, and Dousset), Hopital Pellegrin, Bordeaux, France; Unitat de Neuroimmunologia Clinica (Drs. Montalban and Rovira), Hospital Vall d’Hebron, Barcelona, Spain; and Servico de Neurologia (Dr. de Sa), Hospital de Santa Maria, Lisbon, Portugal.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Rovira
From the NMR Research Unit (Drs. StevensonMiller, and Thompson), Institute of Neurology, Queen Square, London, UK; Neuroimaging Research Unit (Drs. Rovaris and Filippi), Department of Neuroscience, Scientific Institute Ospidale San Raffaele, University of Milan, Italy; University Hospital Free University (Drs. Barkhof and Polman), Amsterdam, the Netherlands; Departments of Neurology and Neuroradiology (Drs. Brochet, Dousset, and Dousset), Hopital Pellegrin, Bordeaux, France; Unitat de Neuroimmunologia Clinica (Drs. Montalban and Rovira), Hospital Vall d’Hebron, Barcelona, Spain; and Servico de Neurologia (Dr. de Sa), Hospital de Santa Maria, Lisbon, Portugal.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. de Sa
From the NMR Research Unit (Drs. StevensonMiller, and Thompson), Institute of Neurology, Queen Square, London, UK; Neuroimaging Research Unit (Drs. Rovaris and Filippi), Department of Neuroscience, Scientific Institute Ospidale San Raffaele, University of Milan, Italy; University Hospital Free University (Drs. Barkhof and Polman), Amsterdam, the Netherlands; Departments of Neurology and Neuroradiology (Drs. Brochet, Dousset, and Dousset), Hopital Pellegrin, Bordeaux, France; Unitat de Neuroimmunologia Clinica (Drs. Montalban and Rovira), Hospital Vall d’Hebron, Barcelona, Spain; and Servico de Neurologia (Dr. de Sa), Hospital de Santa Maria, Lisbon, Portugal.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A.J. Thompson
From the NMR Research Unit (Drs. StevensonMiller, and Thompson), Institute of Neurology, Queen Square, London, UK; Neuroimaging Research Unit (Drs. Rovaris and Filippi), Department of Neuroscience, Scientific Institute Ospidale San Raffaele, University of Milan, Italy; University Hospital Free University (Drs. Barkhof and Polman), Amsterdam, the Netherlands; Departments of Neurology and Neuroradiology (Drs. Brochet, Dousset, and Dousset), Hopital Pellegrin, Bordeaux, France; Unitat de Neuroimmunologia Clinica (Drs. Montalban and Rovira), Hospital Vall d’Hebron, Barcelona, Spain; and Servico de Neurologia (Dr. de Sa), Hospital de Santa Maria, Lisbon, Portugal.
FRCP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Primary and transitional progressive MS
A clinical and MRI cross-sectional study
V.L. Stevenson, D.H. Miller, M. Rovaris, F. Barkhof, B. Brochet, V. Dousset, V. Dousset, M. Filippi, X. Montalban, C.H. Polman, A. Rovira, J. de Sa, A.J. Thompson
Neurology Mar 1999, 52 (4) 839; DOI: 10.1212/WNL.52.4.839

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
524

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Abstract

Background: Ten percent of patients with MS have a progressive course from onset with no history of relapses or remissions. A smaller subgroup follow a similar progressive course but have a single relapse at some point (transitional progressive [TP] MS). To date these patients have been excluded from receiving licensed treatments for MS and from most therapeutic trials.

Objective: To document the clinical and MRI characteristics of a large cohort of progressive patients, including 158 with primary progressive (PP) MS and 33 with TPMS. Data from a small reference group of 20 patients with secondary progressive (SP) MS are also presented for reference.

Methods: Patients were recruited from six European centers. All underwent a clinical assessment including scoring on the Expanded Disability Status Scale (EDSS) and MRI of the brain and spinal cord.

Results: The men-to-women ratio was 81:77 (51% men) in the PP group, 14:19 (42% men) in the TP group, and 5:15 (25% men) in the SP group. The mean age at disease onset was significantly higher in the PP group than it was in the other two groups (PP 40.2 years, TP 34.9 years, SP 28.7 years). On MRI the PP group had lower mean brain T2 and T1 hypointensity lesion loads than the SP group (T2 12.02 versus 27.74 cm3, p = 0.001; T1 4.34 versus 7.04 cm3, p = 0.015). The SP and TP cohorts had significantly more T2-weighted lesions in the spinal cord than the PP patients, and the SP cohort had the greatest degree of atrophy. There was a correlation in the PP and TP patients between EDSS score and brain and spinal cord atrophy (r = 0.3, 0.2, p ≤ 0.006) but not with brain lesion load. The PP and TP patients who presented with spinal cord pathology had significantly lower brain T2 and T1 lesion loads than those with non-spinal cord presentations (p = 0.002).

Conclusions: The monitoring of disease progression in PPMS is difficult, although measures of atrophy correlate with the EDSS and appear most promising. This study increases our understanding of this unique patient group, which will be further expanded with the acquisition of serial data.

  • Received July 16, 1998.
  • Accepted in final form November 21, 1998.
View Full Text

AAN Members

We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.

Google Safari Microsoft Edge Firefox

Click here to login

AAN Non-Member Subscribers

Click here to login

Purchase access

For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)

Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here 

Purchase
Individual access to articles is available through the Add to Cart option on the article page.  Access for 1 day (from the computer you are currently using) is US$ 39.00.  Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means.  The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use.  Distributing copies (electronic or otherwise) of the article is not allowed.

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Methods.
    • Results.
    • Discussion.
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Association Between Fluctuations in Blood Lipid Levels Over Time With Incident Alzheimer Disease and Alzheimer Disease–Related Dementias

Dr. Sevil Yaşar and Dr. Behnam Sabayan

► Watch

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Articles
    Interferon β-1a in primary progressive MS
    An exploratory, randomized, controlled trial
    S.M. Leary, D.H. Miller, V.L. Stevenson et al.
    Neurology, January 14, 2003
  • Articles
    Clinical and laboratory features of primary progressive and secondary progressive MS
    Khurram Bashir, John N. Whitaker et al.
    Neurology, September 01, 1999
  • Articles
    Spinal cord atrophy and disability in MS
    A longitudinal study
    V. L. Stevenson, S. M. Leary, N. A. Losseff et al.
    Neurology, July 01, 1998
  • Articles
    Age and disability accumulation in multiple sclerosis
    A. Scalfari, A. Neuhaus, M. Daumer et al.
    Neurology, September 14, 2011
Neurology: 101 (15)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise